# Beta-Lactam InfusioN Group Study

> **NCT03213990** · NA · COMPLETED · sponsor: **The George Institute** · enrollment: 7203 (actual)

## Conditions studied

- Sepsis

## Interventions

- **OTHER:** Continuous infusion
- **OTHER:** Intermittent infusion

## Key facts

- **NCT ID:** NCT03213990
- **Lead sponsor:** The George Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-26
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-06-29
- **Target enrollment:** 7203 (ACTUAL)
- **Last updated:** 2023-12-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03213990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03213990, "Beta-Lactam InfusioN Group Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03213990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*